.FDA rejects psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Approve MDMA Treatment, Looking For More Research The New York TimesFDA Turns Down Ecstasy-Based Drug The Commercial JournalFDA refuses to permit unique MDMA treatment to address post-traumatic stress disorder, with request for more hearing records CNNFDA rejects initially psychedelic to handle PTSD, asking for more research study The Washington Post.